1-20 of 32
Jeffrey M. Switchenko
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Overall Survival Following First and Second Relapse of DLBCL Treated with Therapies Including Autologous Transplant and CAR-T Cells: Results from the Lion Prospective Observational Registry

Greg Kirkpatrick, Jeffrey M. Switchenko, Melissa Kives, Katelin Baird, Kami J. Maddocks, Jason T. Romancik, Deborah M. Stephens, Harsh Shah, Javier Pinilla-Ibarz, Julio C Chavez, Matthew Matasar, Craig A. Portell, Michelle Churchman, Jonathon B. Cohen, Umar Farooq, Brian K. Link
Journal: Blood
Blood (2023) 142 (Supplement 1): 6325.
https://doi.org/10.1182/blood-2023-187198
Published: 2023
Journal Articles

Ki-67 Expression of 50% Is the Optimal Cut-Off to Predict Survival Outcomes in Mantle Cell Lymphoma (MCL): A Pooled Analysis from CALGB 50403 (Alliance) and MCL Real-World Study Cohort

Narendranath Epperla, Jeffrey M. Switchenko, Susan M. Geyer, Veronika Bachanova, Stefan K. Barta, Alexey Danilov, Natalie S. Grover, Reem Karmali, Brian T. Hill, Nilanjan Ghosh, Timothy S. Fenske, Peter Martin, Brad S. Kahl, Christopher R. Flowers, Brian K. Link, Eric D. Hsi, Kami J. Maddocks, Kristie A. Blum, Thomas M. Habermann, Matthew J. Maurer, Lawrence David Kaplan, Nancy L. Bartlett, John P. Leonard, Jonathon B. Cohen
Journal: Blood
Blood (2023) 142 (Supplement 1): 380.
https://doi.org/10.1182/blood-2023-189505
Published: 2023
Journal Articles

An International Multicohort Study of Conditional Survival and Cause of Death after Achieving Event-Free Survival at 24 Months in Patients with Mantle Cell Lymphoma

Yucai Wang, Melissa C. Larson, Umar Farooq, Sara Ekberg, Karin Ekstroem Smedby, Mikkel Runason Simonsen, Carsten Utoft Niemann, Eric J. Zhao, Alina S. Gerrie, Jeffrey M. Switchenko, David A. Bond, Veronika Bachanova, Stefan K. Barta, Brian T. Hill, Peter Martin, Alexey Danilov, Natalie S. Grover, Reem Karmali, Nilanjan Ghosh, Timothy S. Fenske, Brad S. Kahl, Alexandra Albertsson-Lindblad, Ingrid Cecilia Glimelius, Ahmed Ludvigsen Al-Mashhadi, Thomas Stauffer Larsen, Kami J. Maddocks, Brian K. Link, Jonas Paludo, Grzegorz S. Nowakowski, Thomas M. Habermann, Matthew J. Maurer, Diego Villa, Jonathon B. Cohen, Tarec Christoffer Christoffer El-Galaly, Mats Jerkeman, James R. Cerhan
Journal: Blood
Blood (2023) 142 (Supplement 1): 1656.
https://doi.org/10.1182/blood-2023-182747
Published: 2023
Journal Articles

Social Determinants of Health and Outcomes in Cutaneous T-Cell Lymphoma in the State of Georgia

Pamela B. Allen, Ashley McCook, Jeffrey M. Switchenko, Kevin Ward, Lauren McCullough
Journal: Blood
Blood (2023) 142 (Supplement 1): 2411.
https://doi.org/10.1182/blood-2023-186097
Published: 2023
Journal Articles

Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Real-World Retrospective Study

Tony Z. Zhuang, Ashley Alesia McCook, Jeffrey M. Switchenko, Tim Niyogusaba, Erica Shantha Tarabadkar, Katelin Baird, Colin B. O'Leary, Darina Paulino, Mary Jo Lechowicz, Pamela B. Allen
Journal: Blood
Blood (2022) 140 (Supplement 1): 6575–6576.
https://doi.org/10.1182/blood-2022-162967
Published: 2022
Journal Articles

Differences in Progression and Survival Among Black Patients with Mycosis Fungoides and Sézary Syndrome: A Multicenter Retrospective Analysis at Large Urban Medical Centers

Pamela B. Allen, Subir Goyal, Swaminathan P. Iyer, Sai Talluru, Auris Huen, Irl Brian Greenwell, Jane Scribner, Shel Speegle, Tim Niyogusaba, Sunil Rangarajan, Amitkumar Mehta, Colin B. O'Leary, Anne W. Beaven, Jeffrey M. Switchenko, Amy Ayers, Safiyyah Bhatti, Shalini Krishnasamy, Pierluigi Porcu, Tarsheen Sethi, Francine M. Foss, Mary Jo Lechowicz, Sima Rozati
Journal: Blood
Blood (2022) 140 (Supplement 1): 9431–9433.
https://doi.org/10.1182/blood-2022-170921
Published: 2022
Journal Articles

Bendamustine, Obinutuzumab and Venetoclax Results in High Complete Response Rates in Untreated Mantle Cell Lymphoma

Irl Brian Greenwell, Jeffrey M. Switchenko, Alexander F.M. Craig, Ash A. Alizadeh, Pamela B. Allen, Alicia Escobar, Kelly Valla, Aseala Abousaud, Priya Parikh, Danielle Roberts, Jessica J. Neely, Alexandra Palmer, Kristie A. Blum, Jonathon B. Cohen, Marcela Algave
Journal: Blood
Blood (2022) 140 (Supplement 1): 9373–9374.
https://doi.org/10.1182/blood-2022-167947
Published: 2022
Journal Articles

Tumor-Immune Architecture and the Regulation of Antigen-Specific T-Cell Infiltration in Multiple Myeloma and Premalignant Plasma Cell Disorders

Hope Robinson, Nancy Villa, David L Jaye, Ajay K. Nooka, Alyssa Duffy, Samuel McCachren, Julia Manalo, Jeffrey M. Switchenko, Ava Horvat, Vaunita C Parihar, Jingjing Gong, Yan Liang, Geoffrey Smith, Vikas A Gupta, Lawrence H. Boise, Jonathan L. Kaufman, Craig C Hofmeister, Nisha Joseph, Sagar Lonial, Kavita Dhodapkar, Madhav Dhodapkar
Journal: Blood
Blood (2022) 140 (Supplement 1): 244–245.
https://doi.org/10.1182/blood-2022-169558
Published: 2022
Journal Articles

Weight Change Trends and Impact of Body Mass Index (BMI) on Outcomes in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma, a Retrospective Analysis from the Lymphoma Innovations Orien Network (LION) Consortium

Yazeed Sawalha, Chenxi Du, Jeffrey M. Switchenko, Melissa Kives, Michelle L. Churchman, Deborah M. Stephens, Javier Pinilla Ibarz, Andrew Matthew Evens, Kami J. Maddocks, Brian K. Link, Jonathon B. Cohen, Craig A. Portell
Journal: Blood
Blood (2022) 140 (Supplement 1): 11956–11958.
https://doi.org/10.1182/blood-2022-163681
Published: 2022
Journal Articles

Favorable Overall Survival Following First and Second Relapse of MCL with Availability of Novel Therapies: Results from the Lion Prospective Observational Registry

David A. Bond, Jason T. Romancik, Jeffrey M. Switchenko, Brielle Berkowitz, Jonathan R Day, Umar Farooq, Sabarish Ayyappan, Katelin Baird, Michelle L. Churchman, Andrew M. Evens, Bijal D. Shah, Craig A. Portell, Kami J. Maddocks, Brian K. Link, Jonathon B. Cohen, Deborah M. Stephens
Journal: Blood
Blood (2022) 140 (Supplement 1): 6509–6511.
https://doi.org/10.1182/blood-2022-160306
Published: 2022
Journal Articles

Discontinuation Due to Toxicity Limits Treatment Duration of BTK Inhibitors in Non-Hodgkin Lymphoma

Drew G Gerber, Yichun Cao, Jeffrey M. Switchenko, Kelly Valla, Jonathon B. Cohen
Journal: Blood
Blood (2021) 138 (Supplement 1): 4685.
https://doi.org/10.1182/blood-2021-151791
Published: 2021
Journal Articles

No Difference in Survival Among Black Patients with Mycosis Fungoides and Sézary Syndrome: A Multicenter Retrospective Analysis

Pamela Allen, Subir Goyal, Irl Brian Greenwell, Jane Scribner, Sunil Rangarajan, Amitkumar Mehta, Colin Burke O'Leary, Tim Niyogusaba, Auris Huen, Jeffrey M. Switchenko, Erica Shantha Tarabadkar, Amy Ayers, Shalini Krishnasamy, Pierluigi Porcu, Tarsheen Sethi, Swaminathan P Iyer, Mary Jo Lechowicz
Journal: Blood
Blood (2021) 138 (Supplement 1): 2441.
https://doi.org/10.1182/blood-2021-151911
Published: 2021
Journal Articles

Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrangement Driven Trial, PINR)

Leon Bernal-Mizrachi, Ajay K. Nooka, Leonard Heffner, Craig E. Cole, Jing C. Ye, Ravi Vij, Craig C. Hofmeister, John Rushton, Zhengjia Chen, Subir Goyal, Jeffrey M. Switchenko, Sagar Lonial, Jonathan L. Kaufman
Journal: Blood
Blood (2021) 138 (Supplement 1): 2758.
https://doi.org/10.1182/blood-2021-153922
Published: 2021
Journal Articles

Risk Factors for Progression from Early to Advanced Stage Mycosis Fungoides: A Single Center Retrospective Analysis at the Winship Cancer Institute of Emory University

Pamela Allen, Ashley Alesia McCook, Jeffrey M. Switchenko, Shaunak Varma, Mary Jo Lechowicz, Erica Shantha Tarabadkar
Journal: Blood
Blood (2021) 138 (Supplement 1): 1378.
https://doi.org/10.1182/blood-2021-146590
Published: 2021
Journal Articles

Treatment Patterns and Clinical Outcomes of Patients with Sézary Syndrome at Emory University

Dylan J Martini, Subir Goyal, PhD, Jeffrey M. Switchenko, PhD MS, Mary Jo Lechowicz, MD, Pamela B. Allen, MD MSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-140479
Published: 2020
Journal Articles

Bendamustine, Obinutuzumab and Venetoclax As Induction Therapy for Untreated Mantle Cell Lymphoma

Irl Brian Greenwell, MD, Jeffrey M. Switchenko, PhD MS, Kami J. Maddocks, MD, Brad S. Kahl, MD, Alexander F. M. Craig, MPhil, Ash A. Alizadeh, MD PhD, Pamela B. Allen, MD MSc, Alena Lorretta Marbury, BS, Alicia Escobar, Kelly Valla, PharmD, Miayea Williams, Priya Parikh, Danielle Roberts, PA-C, Jessica J. Neely, PA-C, Alexandra Palmer, NP-C, Kristie A. Blum, MD, Jonathon B. Cohen, MDMS
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-141454
Published: 2020
Journal Articles

Outcomes of Patients with Relapsed Mantle Cell Lymphoma Treated with Venetoclax: A Multicenter Retrospective Analysis

Yazeed Sawalha, MD, Subir Goyal, PhD, Jeffrey M. Switchenko, PhD MS, Jason T. Romancik, MD, Manali Kamdar, MD, Irl Brian Greenwell, MD, Brian T. Hess, MD, Krista Isaac, DO,MS, Craig A. Portell, MD, Alex V. Mejia Garcia, MD, Scott R. Goldsmith, MD, Natalie S Grover, MD, Peter A. Riedell, MD, Reem Karmali, MDMSc, Madelyn Burkart, MD, Michael J Buege, PharmD, Othman S. Akhtar, MD, Pallawi Torka, MD, Anita Kumar, MD, Brian T. Hill, MD, Brad S. Kahl, MD, Jonathon B. Cohen, MDMS
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–6.
https://doi.org/10.1182/blood-2020-138878
Published: 2020
Journal Articles

The Impact of Pre-Diagnosis Tobacco Use in Mantle Cell Lymphoma

Jason Romancik, MD, Jeffrey M. Switchenko, PhD MS, Krithika Shanmugasundaram, MD, Subir Goyal, Oscar Calzada, BS, Michael C. Churnetski, Bhaskar Kolla, MBBS, Veronika Bachanova, MD PhD, James N. Gerson, MD, Stefan K. Barta, MD MRCP, MS, Max J. Gordon, MD, Alexey Danilov, MD PhD, Natalie S Grover, MD, Stephanie Mathews, MD, Madelyn Burkhart, MD, Reem Karmali, MD, Yazeed Sawalha, MD, Brian T. Hill, MD, Nilanjan Ghosh, MD PhD, Steven I Park, MD, Narendranath Epperla, MDMS, David A. Bond, MD, Talha Badar, MD, Kristie A. Blum, MD, Mehdi Hamadani, MD, Timothy S. Fenske, MD, Mary-Kate Malecek, MD, Brad S. Kahl, MD, Peter Martin, FRCPC, MD MS, Jin Guo, MD, Christopher R. Flowers, MD MS, Jonathon B. Cohen, MDMS
Journal: Blood
Blood (2019) 134 (Supplement_1): 5891.
https://doi.org/10.1182/blood-2019-130249
Published: 2019
Journal Articles

Short Time to Treatment Is Associated with Inferior Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma

Narendranath Epperla, MDMS, Jeffrey M. Switchenko, PhD MS, Krithika Shanmugasundaram, MD, Subir Goyal, Oscar Calzada, BS, Michael C. Churnetski, Bhaskar Kolla, MBBS, Veronika Bachanova, MD PhD, James N. Gerson, MD, Stefan K. Barta, MD MRCP, MS, Max J. Gordon, MD, Alexey Danilov, MD PhD, Natalie S Grover, MD, Stephanie Mathews, MD, Madelyn Burkart, MD, Reem Karmali, MD, Yazeed Sawalha, MD, Brian T. Hill, MD, Nilanjan Ghosh, MD PhD, Steven I Park, MD, David A. Bond, MD, Talha Badar, MD, Kristie A. Blum, MD, Mehdi Hamadani, MD, Timothy S. Fenske, MD, Mary-Kate Malecek, MD, Peter Martin, FRCPC, MD MS, Jin Guo, MD, Brad S. Kahl, MD, Christopher R. Flowers, MD MS, Jonathon B. Cohen, MDMS
Journal: Blood
Blood (2019) 134 (Supplement_1): 3997.
https://doi.org/10.1182/blood-2019-128632
Published: 2019
Journal Articles

A Data-Driven Approach to Define Parsimonious Eligibility Criteria in First-Line Clinical Trials for Diffuse Large B-Cell Lymphoma

R. Andrew Harkins, Sharvil Piyush Patel, Michelle J. Lee, MD PhD, Jeffrey M. Switchenko, PhD MS, Christopher R. Flowers, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 3416.
https://doi.org/10.1182/blood-2019-125779
Published: 2019